PIPELINE

PIPELINE

Philogen is a fully integrated company active in the discovery, GMP production and clinical development of immunomodulatory biopharmaceuticals.
We have a leading position in the field of antibody-based therapeutics specific for markers of angiogenesis; at present we have 4 ‘armed antibodies’ in clinical development in the oncology field and 2 in pre-clinical/clinical development in chronic inflammatory disease. The immunocytokines have proven ability to selectively deliver their immunomodulatory payload at sites of disease.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy
X